Autori: Moorkens Evelien
| Naslov | The Expiry of Humira(R) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures (Article) |
| Autori | Moorkens Evelien ... Novakovic Tanja ... (broj koautora 43) |
| Info | FRONTIERS IN PHARMACOLOGY, (2021), vol. 11 br. , str. - |
| Projekat | KULeuvenKU Leuven; Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Policies for biosimilar uptake in Europe: An overview (Article) |
| Autori | Moorkens Evelien ... Kalaba Marija ... (broj koautora 34) |
| Info | PLOS ONE, (2017), vol. 12 br. 12, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
